Intravenous Iron Infusion is Appropriate for This Patient
Yes, intravenous iron infusion is appropriate and should be administered for this patient with iron-deficiency anemia (ferritin 23 ng/mL) scheduled for lumbar fusion in three weeks. The three-week timeframe is insufficient for oral iron to meaningfully correct anemia, and IV iron has been specifically shown to reduce postoperative complications in lumbar fusion patients 1.
Why IV Iron Over Oral Iron in This Case
The critical factor here is timing. While oral iron can be effective, it requires 6-8 weeks to substantially increase hemoglobin levels 2. With only three weeks until surgery, oral iron will not provide adequate correction of the anemia before the procedure.
IV iron demonstrates peak hemoglobin response at 2-3 weeks after administration 3, making the current three-week window actually optimal for IV iron therapy. This timing allows maximal hemoglobin improvement before surgery while the patient still has adequate iron stores at the time of the procedure.
Evidence Supporting IV Iron in Preoperative Lumbar Fusion
The most compelling evidence comes from a 2025 study specifically examining lumbar fusion patients 1. This research demonstrated that:
- Preoperative iron supplementation in IDA patients undergoing lumbar fusion significantly reduced:
- Pulmonary embolism
- Acute kidney injury
- Surgical site infections
- Urinary tract infections
- 90-day readmission rates
- Total hospital costs
These are meaningful patient-centered outcomes affecting morbidity and quality of life, not just laboratory values.
Guideline Support for IV Iron
The 2024 AGA guidelines provide clear indications for IV iron 4:
IV iron should be used when:
- The patient has a condition where oral iron is unlikely to work effectively
- There is insufficient time for oral iron to correct deficiency
- Ferritin levels do not improve with oral iron trial
All three conditions apply here: the inflammatory state from impending surgery may impair oral iron absorption, three weeks is insufficient time, and there has been no prior trial.
Practical Implementation
Preferred formulations: Use IV iron preparations that allow total dose infusion in 1-2 visits rather than multiple infusions 4, 5. Options include:
Timing: Administer as soon as possible, ideally starting this week to maximize the 2-3 week window for peak hemoglobin response 3.
Safety considerations: True anaphylaxis to IV iron is exceedingly rare (<1:200,000 administrations) 5. Most reactions are complement activation-related pseudo-allergy (CARPA/Fishbane reactions), which are physiologically distinct from anaphylaxis and manageable 5. The safety profile is excellent, with no increased infection risk 2.
Common Pitfalls to Avoid
Do not delay for an oral iron trial in this timeframe. The three-week window is too short, and attempting oral iron first will waste valuable time when the patient could be receiving definitive therapy.
Do not assume inflammation from surgery planning contraindicates IV iron. In fact, inflammation is an indication FOR IV iron rather than oral, as it impairs duodenal absorption 4, 2.
Do not use older multi-dose IV iron regimens. Modern formulations allowing 1-2 total dose infusions are preferred for convenience and equivalent safety 4.
The Bottom Line
With ferritin of 23 ng/mL confirming iron-deficiency anemia and only three weeks until major spinal surgery, IV iron infusion is not just appropriate—it is the optimal strategy to reduce surgical complications, transfusion requirements, and improve postoperative recovery 1, 8, 2. The evidence specifically in lumbar fusion patients demonstrates meaningful reductions in morbidity when preoperative iron supplementation is provided 1.